乳酸可改善肝硬化危重患者短期死亡率的预测:一项多国研究
研究在汉堡-埃彭多夫大学医学中心(n=566,推导队列)及维也纳医科大学和鲁汶大学医院(n=250,验证队列)纳入入住ICU的肝硬化患者,评估动脉乳酸水平及清除率对28天和1年死亡率的预测价值。入院乳酸与器官衰竭数目及28天死亡率直接相关(AUROC 0.72;P<0.001),将乳酸纳入CLIF-C ACLFs(CLIF-C ACLFsLact)后预测28天死亡率显著优于原评分。
要点
- 入院乳酸与器官衰竭数目及28天死亡率直接相关(AUROC 0.72;P<0.001)。
- 入院乳酸和12小时乳酸清除率(入院乳酸≥5 mmol/L者)是1年死亡率的显著预测因素,独立于CLIF-C ACLFs。
- 乳酸调整的CLIF-C ACLFsLact预测28天死亡率显著优于原CLIF-C ACLFs。
核心结论
- 乳酸水平适当反映疾病严重程度和器官衰竭,并与肝硬化危重患者短期死亡率独立相关。
- 乳酸是简单而准确的预后标志物,其纳入显著改善了CLIF-C ACLFs的性能。
研究设计与样本
- 多国研究,在汉堡-埃彭多夫大学医学中心(n=566,推导队列)及维也纳医科大学和鲁汶大学医院(n=250,验证队列)纳入入住ICU的肝硬化患者。
- 入院时及最初24小时内测量动脉乳酸,随访1年并评估结局。
主要发现
- 入院乳酸与器官衰竭数目及28天死亡率直接相关(AUROC 0.72;P<0.001)。
- 6、12和24小时乳酸随访测量同样与28天死亡率相关(所有P<0.001,所有AUROC>0.70)。
- 在血清乳酸≥5 mmol/L的患者中,乳酸清除率对28天死亡率有显著预测能力。
- 入院乳酸和12小时乳酸清除率(入院乳酸≥5 mmol/L者)分别是1年死亡率的显著预测因素,独立于CLIF-C ACLFs。
- 乳酸调整的CLIF-C ACLFsLact在推导和验证队列中预测28天死亡率均显著优于原CLIF-C ACLFs。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lactate levels and lactate clearance are known predictors of outcome in critically ill patients in the intensive care unit (ICU). The prognostic value of lactate is not well established in liver cirrhosis and acute-on-chronic liver failure (ACLF). The aim of this study was to assess the prognostic value of lactate levels and clearance in critically ill patients with cirrhosis. Patients with cirrhosis admitted to the ICU were studied at the University Medical Center Hamburg-Eppendorf (n = 566, derivation cohort) and the Medical University of Vienna and the University Hospitals Leuven (n = 250, validation cohort). Arterial lactate was measured on admission and during the first 24 hours. Patients were followed for 1 year and outcome was assessed. Admission lactate was directly related to the number of organs failing and to 28-day mortality (area under receiver operating characteristic [AUROC] 0.72; P < 0.001). This also applied to lactate follow-up measurements after 6, 12, and 24 hours (P < 0.001 for all, AUROC > 0.70 for all). Lactate clearance had significant predictive ability for 28-day mortality in patients with elevated serum lactate ≥5 mmol/L. Admission lactate and 12-hour lactate clearance (in patients with admission lactate ≥5 mmol/L), respectively, were identified as significant predictors of 1-year mortality, independent of Chronic Liver Failure Consortium acute-on-chronic liver failure score (CLIF-C ACLFs). A lactate-adjusted CLIF-C ACLFs was developed (CLIF-C ACLFsLact ), which performed significantly better than the original CLIF-C ACLFs in prediction of 28-day mortality in the derivation and validation cohort. Conclusion: Lactate levels appropriately reflect severity of disease and organ failure and were independently associated with short-term mortality in critically ill patients with liver cirrhosis. Lactate is a simple but accurate prognostic marker, and its incorporation improved performance of CLIF-C ACLFs significantly.
引用
- Drolz A, Horvatits T, Rutter K, et al. Lactate Improves Prediction of Short-Term Mortality in Critically Ill Patients With Cirrhosis: A Multinational Study. Hepatology. 2018. PMID: 30070381. doi:10.1002/hep.30151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。